| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairperson &CEO
1 company
Rothblatt Martine A is a Chairperson &CEO at UTHR. Recent filings cover 0 purchases and 462 sales. Those positions are worth an estimated $175.2M at current prices.
Our model assigns Rothblatt Martine A a middling insider score of 58/100, based on 304 past trades. Over a 12-month horizon, 53.6% of those trades were profitable, with an average 12-month return of -1.6%.
Rothblatt Martine A's largest disclosed position is in UTHR as Chairperson &CEO, worth about $175.2M. The recent filings there lean toward selling, a net 355,916 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $534.66 | $5,079,274.86 | -2.8% | |
| Oct 15, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $546.65 | $5,193,199.71 | -2.8% | |
| Oct 14, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $539.99 | $5,129,873.02 | -2.8% | |
| Oct 13, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,568 | $545.61 | $5,220,350.85 | -2.9% | |
| Oct 12, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $550.70 | $5,231,666.41 | -2.8% | |
| Oct 9, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $544.94 | $5,176,935.89 | -2.8% | |
| Oct 8, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $534.31 | $5,075,918.83 | -2.8% | |
| Oct 7, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 7,556 | $549.69 | $4,153,482.87 | -2.3% | |
| Oct 6, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $538.67 | $5,117,411.92 | -2.8% | |
| Oct 5, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $541.64 | $5,145,537.07 | -2.8% |